Bioinformatics and integrated pharmacology network to identify the therapeutic targets and potential molecular mechanism of alpha‐lipoic acid on primary ovarian insufficiency
article
OA: bronze
CC0
AI-generated summary
This study used bioinformatics and network pharmacology to identify 152 potential targets and confirmed ALA's therapeutic role in primary ovarian insufficiency via multiple pathways, including cAMP and PI3K/AKT signaling.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Women experiencing primary ovarian insufficiency (POI) are more likely to experience infertility, and its incidence is increasing worldwide annually. Recently, the role of alpha-lipoic acid (ALA) in the treatment of POI has been reported. However, details of the potential pharmacological targets and related molecular pathways of ALA remain unclear and need to be elucidated. Thus, this study aims to elucidate the potential therapeutic target and related molecular mechanism of ALA on POI. First, the potential targets of POI and ALA-related targets were downloaded from online public databases. Subsequently, the overlapped target genes between POI and ALA were acquired, and gene ontology (GO), Kyoto encyclopedia of genes and genomes (KEGG) analysis, protein-protein interaction (PPI) networks were performed and constructed. Finally, molecular docking was performed to verify protein-to-protein effect. A total of 152 potential therapeutic targets were identified. The biological processes of the intersecting targets were mainly involved in the cellular response to peptides, response to xenobiotic stimuli, and response to peptide hormones. The highly enriched pathways were the cAMP, PI3K/AKT, estrogen, progesterone mediated oocyte maturation, and apoptosis signaling pathways. The top 10 hub targets for ALA in the treatment of POI were STAT3, STAT1, CASP3, MTOR, PTGS2, CASP8, HSP90AA1, PIK3CA, MAPK1, and ESR1. The binding between ALA and all top hub targets were verified using the molecular docking analysis. In summary, using the systematic integrated pharmacology network and bioinformatics analysis, this study illustrated that ALA participates in the treatment of POI via multiple targets and multiple pathways mechanisms.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- ESHRE Guideline: management of women with premature ovarian insufficiency 2016
- The Combination of N‐Acetyl Cysteine, Alpha‐Lipoic Acid, and Bromelain Shows High Anti‐Inflammatory Properties in Novel <i>In Vivo</i> and <i>In Vitro</i> Models of Endometriosis 2015
- α-Lipoic Acid Vaginal Administration Contrasts Inflammation and Preterm Delivery in Rats 2018
References (55)
- ESHRE Guideline: management of women with premature ovarian insufficiency via openalex
- The Combination of N‐Acetyl Cysteine, Alpha‐Lipoic Acid, and Bromelain Shows High Anti‐Inflammatory Properties in Novel <i>In Vivo</i> and <i>In Vitro</i> Models of Endometriosis via openalex
- α-Lipoic Acid Vaginal Administration Contrasts Inflammation and Preterm Delivery in Rats via openalex
- W1981882535 via openalex
- W1985198089 via openalex
- W1987945086 via openalex
- W1988428427 via openalex
- W1995380492 via openalex
- W2002196794 via openalex
- W2035618305 via openalex
- W2037753178 via openalex
- W2041256198 via openalex
- W2044004638 via openalex
- W2048863570 via openalex
- W2055801007 via openalex
- W2059844002 via openalex
- W2070066734 via openalex
- W2074506682 via openalex
- W2076731963 via openalex
- W2109299391 via openalex
- W2109446581 via openalex
- W2113995809 via openalex
- W2115364443 via openalex
- W2121722368 via openalex
- W2123901876 via openalex
- W2124020069 via openalex
- W2124556975 via openalex
- W2143628100 via openalex
- W2163254153 via openalex
- W2732516376 via openalex
- W2800445072 via openalex
- W2803469527 via openalex
- W2807540116 via openalex
- W2864359718 via openalex
- W2919421583 via openalex
- W2947956121 via openalex
- W2951509935 via openalex
- W2984403034 via openalex
- W3000105651 via openalex
- W3003318424 via openalex
- W3006935204 via openalex
- W3007412727 via openalex
- W3009972969 via openalex
- W3039761696 via openalex
- W3044358886 via openalex
- W3080660504 via openalex
- W3192458679 via openalex
- W4205395164 via openalex
- W4214775356 via openalex
- W6607327656 via openalex
- W6663390131 via openalex
- W21889106 via openalex
- doi:10.1007/s10735-013-9485-8 via openalex
- W1917056365 via openalex
- W1968583736 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK